Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH1110760852
Tue, 19.03.2024
PolyPeptide Group
PolyPeptide Group
/ Key word(s): AGMEGM
PolyPeptide publishes invitation to the annual General Meeting 2024
19.03.2024 / 07:00 CET/CEST
Media release
PolyPeptide publishes invitation to the annual General Meeting 2024
Baar, 19 March 2024 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligon [ … ]
Tue, 12.03.2024
PolyPeptide Group
Media release – ad hoc announcement pursuant to Art. 53 LR
PolyPeptide with record revenue growth of 43% in H2 2023 versus H1 2023; operational improvements yielding increased profitability and cash flow
Baar, 12 March 2024 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligonucleotide-based active pharmaceutical in [ … ]
Tue, 31.10.2023
PolyPeptide Group
PolyPeptide Group
/ Key word(s): Partnership/ESG
PolyPeptide signs scientific collaboration agreement
31.10.2023 / 07:00 CET/CEST
Media Release
PolyPeptide signs scientific collaboration agreement
Strasbourg, 31 October 2023 – PolyPeptide today announced the signing of a collaboration agre [ … ]
Mon, 02.10.2023
PolyPeptide Group
PolyPeptide Group
/ Key word(s): Financing
PolyPeptide secures revolving credit facility
02.10.2023 / 07:00 CET/CEST
Media Release
PolyPeptide secures revolving credit facility
Baar, 2 October 2023 – PolyPeptide Group AG (SIX: PPGN) announces the signing of a revolving credit facility agreement with Credit S [ … ]
Tue, 15.08.2023
PolyPeptide Group
Media release – ad hoc announcement pursuant to Art. 53 LR
Transformational progress taking shape, profitability impacted by rapid expansion – appointment of Marc Augustin as new CFO
Baar, 15 August 2023 – PolyPeptide today announced its results for H1 2023, updated guidance for 2023 and the appointment of its new CFO:
Reported re [ … ]
Thu, 13.07.2023
PolyPeptide Group
Media Release – ad hoc announcement pursuant to Art. 53 LR
PolyPeptide delivers revenue of around EUR 132 million for H1 – expects net loss for H1 and full year 2023
Baar, July 13th, 2023 – PolyPeptide Group AG (SIX: PPGN) achieves H1 2023 revenue of around EUR 132 million driven by strong momentum in its peptide business. It expects 2023 to be [ … ]
Thu, 13.07.2023
PolyPeptide Group
Media Release – ad hoc announcement pursuant to Art. 53 LR
PolyPeptide delivers revenue of around EUR 132 million for H1 – expects net loss for H1 and full year 2023
Baar, July 13th, 2023 – PolyPeptide Group AG (SIX: PPGN) achieves H1 2023 revenue of around EUR 132 million driven by strong momentum in its peptide business. It expects 2023 to be [ … ]
Tue, 09.05.2023
PolyPeptide Group
PolyPeptide Group
/ Key word(s): Partnership
PolyPeptide and Numaferm announce partnership to leverage their expertise for the more sustainable production of peptide-based APIs
09.05.2023 / 20:40 CET/CEST
Media release
PolyPeptide and Numaferm announce partnership to leverage their expertise for the more sustainable [ … ]
Tue, 09.05.2023
PolyPeptide Group
PolyPeptide Group
/ Key word(s): Partnership
PolyPeptide and Numaferm announce partnership to leverage their expertise for the more sustainable production of peptide-based APIs
09.05.2023 / 20:40 CET/CEST
Media release
PolyPeptide and Numaferm announce partnership to leverage their expertise for the more sustainable [ … ]
Wed, 12.04.2023
PolyPeptide Group
PolyPeptide Group
/ Key word(s): AGMEGM
PolyPeptide announces results of the annual General Meeting 2023
12.04.2023 / 19:18 CET/CEST
Media Release
PolyPeptide announces results of the annual General Meeting 2023
Baar, 12 April 2023 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligonucleotide- [ … ]